"Aztreonam" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
| Descriptor ID |
D001398
|
| MeSH Number(s) |
D02.065.589.099.500.044 D02.886.108.500.044 D03.383.411.350.044 D03.633.100.300.500.044
|
| Concept/Terms |
Aztreonam- Aztreonam
- Az-threonam
- Az threonam
- Azthreonam
|
Below are MeSH descriptors whose meaning is more general than "Aztreonam".
Below are MeSH descriptors whose meaning is more specific than "Aztreonam".
This graph shows the total number of publications written about "Aztreonam" by people in this website by year, and whether "Aztreonam" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 |
| 2006 | 0 | 1 | 1 |
| 2025 | 0 | 1 | 1 |
| 2026 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Aztreonam" by people in Profiles.
-
Ceftazidime/avibactam and aztreonam combined with an aminoglycoside combat metallo-?-lactamase-producing Klebsiella pneumoniae. Antimicrob Agents Chemother. 2026 03 04; 70(3):e0154025.
-
Pharmacodynamic insights to support pneumonia treatment in a patient co-infected with two carbapenem-resistant bacteria. Int J Antimicrob Agents. 2025 Dec; 66(6):107633.
-
Transient neutrophilic thrombophagocytosis associated with Citrobacter freundii septicemia. Arch Pathol Lab Med. 2006 Dec; 130(12):1754-5.
-
Treatment of nosocomial postoperative pneumonia in cancer patients: a prospective randomized study. Ann Surg Oncol. 2001 Mar; 8(2):179-86.
-
Selection and characterization of amino acid substitutions at residues 237-240 of TEM-1 beta-lactamase with altered substrate specificity for aztreonam and ceftazidime. J Biol Chem. 1996 Sep 13; 271(37):22538-45.
-
Concomitant crystal and septic arthritis. Orthopedics. 1996 Jul; 19(7):613-7.
-
A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients. Cancer. 1996 Apr 01; 77(7):1386-94.
-
[Clinical efficacy of aztreonam in patients with complicated urinary tract infections]. Hinyokika Kiyo. 1988 Dec; 34(12):2225-32.
-
Aztreonam therapy in neutropenic patients with cancer. Am J Med. 1986 Aug; 81(2):243-8.
-
Antimicrobial update. Drug Intell Clin Pharm. 1986 Jul-Aug; 20(7-8):583-6.